Buffalo, N.Y. The primary thesis of this book is that greedy drug companies, along with government and professional bodies who have grown dependent on industry funding, have colluded for many years to rip off the American public and expose patients to the unnecessary risks of new drugs that by and large are no better than existing products but are more dangerous and expensive. The book suggests that in the case of psychiatry and some other fields, new illnesses are created or inappropriately expanded by manufacturers looking to create new markets for these drugs, often with the help of physicians and investigators who are paid to support this effort. The editor and all but one contributor, who is a family physician, are sociologists, and the book has a sociological and, at times, polemical orientation. For example, it is argued that attention deficit hyperactivity disorder has been diagnosed more frequently recently because drug companies have developed new treatments for it, the promotion of which has led to more new "patients." The book also includes a discussion on how social anxiety disorder, which was once vanishingly rare, is now common because manufacturers have gotten an indication for existing products, such as
The Risks of Prescription Drugs
Abstract
Buffalo, N.Y. The primary thesis of this book is that greedy drug companies, along with government and professional bodies who have grown dependent on industry funding, have colluded for many years to rip off the American public and expose patients to the unnecessary risks of new drugs that by and large are no better than existing products but are more dangerous and expensive. The book suggests that in the case of psychiatry and some other fields, new illnesses are created or inappropriately expanded by manufacturers looking to create new markets for these drugs, often with the help of physicians and investigators who are paid to support this effort. The editor and all but one contributor, who is a family physician, are sociologists, and the book has a sociological and, at times, polemical orientation. For example, it is argued that attention deficit hyperactivity disorder has been diagnosed more frequently recently because drug companies have developed new treatments for it, the promotion of which has led to more new "patients." The book also includes a discussion on how social anxiety disorder, which was once vanishingly rare, is now common because manufacturers have gotten an indication for existing products, such asPreview Only. This article cannot be rented because we do not currently have permission from the publisher.
/lp/american-psychiatric-publishing-inc-journal/the-risks-of-prescription-drugs-591PmkKuwt
Welcome to DeepDyve! Rent Premier Research Articles and Save Up to 90%
Preview Only
The Risks of Prescription Drugs
Dubovsky, Steven L.
Follow American Journal of Psychiatry
, Volume 168 (10): 1124
American Psychiatric Publishing, Inc (Journal) – Oct 1, 2011
More Info
More Like This Article
View All dataSource[]=actageo&dataSource[]=aspet&dataSource[]=aaos&dataSource[]=aacc&dataSource[]=aacr&dataSource[]=aea&dataSource[]=aip&dataSource[]=ajnr&dataSource[]=ams&dataSource[]=aps_physical&dataSource[]=appi_book&dataSource[]=appi_journal&dataSource[]=apha&dataSource[]=asip&dataSource[]=asm&dataSource[]=asn&dataSource[]=aspb&dataSource[]=avs&dataSource[]=annual_reviews&dataSource[]=arxiv&dataSource[]=acm&dataSource[]=berghahn&dataSource[]=cabi&dataSource[]=clinical_trials&dataSource[]=dailymed&dataSource[]=degruyter&dataSource[]=du_press&dataSource[]=esa&dataSource[]=eu_press&dataSource[]=elsevier&dataSource[]=emerald&dataSource[]=ejtr&dataSource[]=emea&dataSource[]=epo&dataSource[]=faseb&dataSource[]=gsa&dataSource[]=health_affairs&dataSource[]=hindawi&dataSource[]=imanager&dataSource[]=imedpub&dataSource[]=informa_healthcare&dataSource[]=informs&dataSource[]=iop&dataSource[]=iucr&dataSource[]=iospress&dataSource[]=jbjs&dataSource[]=leftcoast&dataSource[]=lu_press&dataSource[]=mesharpe&dataSource[]=mary_ann_liebert&dataSource[]=medline&dataSource[]=mit_press&dataSource[]=nature&dataSource[]=oxford&dataSource[]=pier_professional&dataSource[]=pnas&dataSource[]=portlandpress&dataSource[]=psyc_articles&dataSource[]=psyc_books&dataSource[]=psyc_critiques&dataSource[]=plos_journal&dataSource[]=pubmed_central&dataSource[]=rsna&dataSource[]=rockefeller&dataSource[]=rcn&dataSource[]=ria&dataSource[]=rsc&dataSource[]=sage&dataSource[]=spie&dataSource[]=springer_journal&dataSource[]=springer&dataSource[]=taylor_francis&dataSource[]=aps&dataSource[]=the_scientist&dataSource[]=uc_press&dataSource[]=uspto_abstract&dataSource[]=wiley&dataSource[]=pct
© 2012 DeepDyve, Inc. All rights reserved.
Terms of Service | Privacy Policy
